0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Review | 
Daniel J. Brotman, MD; Hasan M. Shihab, MBChB, MPH; Kalpana R. Prakasa, MBBS, MS; et al.
JAMA Surg. 2013;148(7):675-686. doi:10.1001/jamasurg.2013.72.
Includes: Supplemental Content

Viewpoint | 
Richard F. Edlich, MD, PhD; Julie A. Garrison, BS; Wendie B. Smith, BS
JAMA Surg. 2013;148(5):406-407. doi:10.1001/jamasurg.2013.30.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Viewpoint  | 
The US Food and Drug Administration’s Proposed Rule to Increase Regulation of Indoor Tanning Devices
Elliot J. Coups, PhD; Alan C. Geller, MPH, RN; Sherry L. Pagoto, PhD
JAMA Internal Medicine
Research Letter  | 
Accuracy of Wearable Devices for Estimating Total Energy Expenditure Comparison With Metabolic Chamber and Doubly Labeled Water Method
Haruka Murakami, PhD; Ryoko Kawakami, PhD; Satoshi Nakae, MSc; et al.
JAMA Cardiology
Viewpoint  | 
The US Food and Drug Administration 515 Program Initiative Addressing the Evidence Gap for Widely Used, High-Risk Cardiovascular Devices?
Vinay K. Rathi, BA; Aaron S. Kesselheim, MD, JD, MPH; Joseph S. Ross, MD, MHS
JAMA Cardiology
Viewpoint  | 
The US Food and Drug Administration Premarket Approval Process and the 515 Program Initiative View From a Panel Chair
Richard L. Page, MD